HOOD enters Q2 earnings season with analysts racing to lift targets, short sellers quietly rebuilding positions, and a stock that just bounced 5.6% in a single session after sliding nearly 9% on the week.
The Street has turned notably constructive over the past month. BTIG launched coverage this week with a Buy and a $125 target — well above the current $98.69 close. Goldman Sachs raised its target to $105 from $95 in early June. Argus followed with a move to $110 from $90, and Mizuho lifted to $115 from $110. The consensus sits at Buy with a mean target near $103, roughly in line with where the stock is trading. Citizens stands out as the outlier, holding a $155 target that implies far greater upside than the pack. On valuation, the stock trades at 38x trailing earnings and 8x book — both up meaningfully over the past 30 days, reflecting the stock's 33% run last month. ORTEX factor scores add nuance: near-perfect 94th-percentile reads on both 30-day EPS momentum and analyst recommendation dispersion suggest the fundamental narrative has been sharpening quickly, even as the 90-day EPS momentum rank sits at a more modest 21st percentile.
Short interest is rebuilding, and the pace of that move is worth tracking. Bears added roughly 6% to their position over the past week, pushing short interest to 4.8% of the free float — about 37.7 million shares. That's a meaningful jump from the 35 million range that prevailed throughout most of June. The monthly increase is steeper still, at 16%. The short score has edged up steadily this week to 36.9, its highest point in the trailing 10-day window, signalling modest incremental pressure from the short side. Still, the borrow market tells a very different story: availability is extremely loose at 1,351% — more than 13 shares available to borrow for every one currently lent out — and cost to borrow is just 0.47%, even after a 10% weekly rise. Short sellers face no friction entering or expanding positions. The setup looks more like a stock that some investors want to fade into strength than one under genuine squeeze pressure.
Options positioning leans slightly bullish for this name. The put/call ratio came in at 0.62 on Thursday, a touch below its 20-day average of 0.64, with a z-score of -1.1 — meaning call activity is running modestly above its recent norm. The PCR is near its 52-week low of 0.56, suggesting the options market has drifted away from the more defensive posture seen earlier this year when the ratio peaked near 0.74. That tilt fits the broader tone: retail-adjacent investors trading calls into momentum.
Founder Baiju Bhatt sold just over 57,000 shares across multiple tranches on June 11, netting roughly $4.9 million. CFO Shiv Verma followed on June 15 with a smaller disposal. Neither transaction is large relative to Bhatt's 6.1% stake of around 55 million shares, and all trades carry a low significance score. The more interesting counter-signal came from Ribbit Capital, which bought 250,000 shares on June 5 at $80.74 — a $20 million addition by a venture backer that has held the stock since before its IPO. The 90-day insider net is a positive 865,000 shares with a net positive value, though that figure is shaped primarily by the Ribbit purchase.
Earnings history is a relevant backdrop here. The last two quarterly prints produced next-day drops of 8.7% and 15.2% respectively, with both losses extending into the five-day window. The next event is scheduled for July 29. With Q2 results just over a month out, the question for the weeks ahead is whether the fresh wave of analyst upgrades and rising short interest will push the stock toward $103–$110 consensus territory before the print — or whether the rebuilding short base and post-rally fatigue keep pressure on the name in the interim.
See the live data behind this article on ORTEX.
Open HOOD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
